Clinical Scorecard: Utilizing Intravoxel Incoherent Motion alongside Standard MRI for Distinguishing Benign, Intermediate, and Malignant Fibrous Soft-Tissue Tumors

At a Glance

Key Highlights

• Malignant tumors show higher heterogeneity and contrast enhancement compared to benign tumors.
• IVIM parameters effectively differentiate between benign, intermediate, and malignant fibrous STTs.
• Standard-ADCmean and Dmean values are critical in distinguishing tumor types.
• Combination of conventional MRI signs and IVIM parameters yields the highest diagnostic accuracy.
• Statistical significance was achieved with p < 0.05 in various comparisons.

Guideline-Based Recommendations

Diagnosis

• Utilize IVIM alongside conventional MRI for accurate differentiation of fibrous STTs.

Management

• Consider surgical resection for intermediate tumors and combined treatment for malignant tumors.

Monitoring & Follow-up

• Follow-up with imaging for benign tumors, and assess treatment response in intermediate and malignant cases.

Risks

• Misdiagnosis due to overlapping MRI features between benign and malignant tumors.

Patient & Prescribing Data

Patients with pathologically proven fibrous tumors

Treatment varies based on tumor classification; benign tumors may be observed, while malignant tumors require aggressive intervention.

Clinical Best Practices

• Incorporate IVIM parameters in routine MRI assessments for fibrous STTs.
• Ensure accurate histopathological classification to guide treatment decisions.

Related Resources & Content

• World Health Organization Classification of STTs